Increasing Incidence of Cardiovascular Diseases (CVDS) and Obesity - Forecasts to 2014–2021 (USD Million)
According to the new market research
report "Cholesterol
Screening/ Cholesterol Lab Testing Services Market by Type of Customer
(Physician/Provider, Hospital, Employer, Health Plan, MCO, Government, ACO,
IDN, Patient), Geography (North America, Europe) & Qualitative Assessment -
Forecasts to 2021", published by MarketsandMarkets™, analyzes
and studies the major market drivers, restraints/challenges, and opportunities.
Don’t miss out on business
opportunities in Cholesterol Screening/ Cholesterol Lab Testing Services
Market.
Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=180941049
Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=180941049
Factors such as increasing
incidence of cardiovascular diseases and obesity, physician preference of
laboratory testing rather self-testing, growing awareness and adoption of
preventive healthcare, government initiatives to improve the quality of
testing, and rapid growth in the geriatric population are propelling the growth
of this market. Moreover, emerging economies offer significant growth
opportunities for players operating in the cholesterol testing services market.
On the other hand, rapidly growing home/self-testing and emergence of non-invasive
cholesterol testing methods are the major factors that may limit growth of the
market to a certain extent.
The cholesterol testing
services market is segmented based on type of customer and region. Based on
type of customer, the market is segmented into physicians/providers and
hospitals; employers, health plans, and Managed Care Organizations (MCOs);
government agencies, Accountable Care Organizations (ACOs), and Integrated
Delivery Networks (IDNs); and patients. The patient-driven cholesterol testing
segment is expected to grow at the highest CAGR during the forecast period,
mainly due to increasing awareness and adoption of preventive healthcare,
availability of lab test services for patients without any physician
intervention thus reducing the waiting time to get appointment from physicians,
and online access to reports and readings through smartphones.
Browse and in-depth TOC on " Cholesterol Testing Services Market "
33 – Tables
21 - Figures
139 - Pages
View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/cholesterol-testing-services-market-180941049.html
33 – Tables
21 - Figures
139 - Pages
View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/cholesterol-testing-services-market-180941049.html
The report categorizes the cholesterol testing market on the basis
of type of customer and region. Based on type of customer, the market is
segmented into physicians/providers and hospitals; employers, health plans, and
Managed Care Organizations (MCOs); government agencies, Accountable Care Organizations
(ACOs), and Integrated Delivery Networks (IDNs); and patients. In 2016, the
physicians/providers and hospitals segment is projected to account for the
largest share of the market. The large share of this segment can be attributed
to factors such as dependence of physicians on cholesterol test results for
making CVD risk assessments and treatment decisions and reimbursement of tests
that are prescribed by physicians/doctors.
Request for Free Sample Report @ https://www.marketsandmarkets.com/requestsample.asp?id=180941049
The cholesterol testing market is segmented on the
basis type of customer and region. Based on type of customer, the market is
segmented into physicians/providers and hospitals; employers, health plans, and
Managed Care Organizations (MCOs); government agencies, Accountable Care
Organizations (ACOs), and Integrated Delivery Networks (IDNs); and patients.
Companies in the market are coming up with innovative offerings to provide
accurate and up-to-date diagnostic information to their customers. In November
2016, Quest Diagnostics (U.S.) launched the QuestDirect, a new
patient-initiated testing service, in the U.S. This new service will allow the
customers better manage their health by ordering certain lab tests directly
without any physician intervention.
Based on region, the cholesterol testing services market is
segmented into North America, Europe, Asia, and RoW. North America is expected
to dominate the global cholesterol testing market in 2016, with the U.S.
accounting for a major share. Asia is projected to be the fastest-growing
region in terms of CAGR during the forecast period. This is due to the large
population base, increased prevalence of cardiovascular diseases, and growing
number of testing facilities in the Asian region.
Key
Players:
Major players in the cholesterol testing market include Laboratory Corporation
of America Holdings (LabCorp) (U.S.), Quest Diagnostics Incorporated (U.S.),
Eurofins Scientific (Luxembourg), Spectra Laboratories Inc. (U.S.), Unilabs
(Switzerland), SYNLAB International GmbH (Germany), Bio-Reference Laboratories
Inc. (U.S.), Clinical Reference Laboratory, Inc. (CRL) (U.S.), ACM Medical
Laboratory (U.S.), and Adicon Clinical Laboratory (China).
Comments
Post a Comment